Method for the site-specific covalent cross-linking of antibodies to surfaces
US12270809B2 · kind B2 · utility
0Cited by
6References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 22, 2021 |
| Grant date | Apr 8, 2025 |
| Priority date | — |
| Expiry date | Dec 8, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to conjugate antibody, drug and nanoparticle compositions and methods of generating the same. This invention further relates to methods of using same for imaging, diagnosing or treating a disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.